Indian minister threatens Novartis with compulsory licensing
According to a Reuters report, the Indian health minister has asked Novartis to withdraw its action challenging India's patent laws. Anbumani Ramadoss hinted that should the case go the wrong way from the Indian government's perspective, it may…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.